Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Nureca Ltd. (NURECA) Stock Price & Analysis

NURECA Stock Chart & Stats

₹298.50₹4.70(1.60%)
At close: 3:26 PM GMT+5:30
₹300₹325₹3503 Aug17 Aug31 Aug15 Sep28 Sep12 Oct26 Oct
Day’s Range
INR 290.55 - INR 300.00
52-Week Range
INR 200.10 - INR 375.00
Previous Close
INR 304.00
Volume
N/A
Average Volume (3M)
668
Market Cap
INR 2.85B
Enterprise Value
INR 2.79B
Total Cash (Recent Filing)
INR 735.52M
Total Debt (Recent Filing)
INR 66.01M
Price to Earnings (P/E)
62.0
Beta
0.98
Next Earnings
Feb 05, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Feb 24, 2022
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage limits financial risk and preserves flexibility for inventory, product development, and distribution investment. This conservative funding structure is especially valuable because it gives Nureca greater resilience when earnings fluctuate and reduces dependence on external financing.

Revenue Recovery And Profitability

The return to revenue growth and two consecutive profitable years indicates that Nureca has regained operating traction after earlier volatility. Sustained sales recovery can strengthen brand reach and provide a foundation for improving earnings, provided margins remain positive as the business expands.

Owned Consumer Healthcare Brands

Owned brands give Nureca control over a broad consumer healthcare portfolio spanning diagnostic, monitoring, therapy, and wellness products. Selling through online storefronts and marketplaces supports access to end consumers and creates a scalable model for extending product coverage.

Bears Say

Thin And Volatile Margins

Low margins leave limited room to absorb discounts, logistics costs, returns, or weaker demand without affecting earnings. The sharp historical swings in revenue and profitability also make future earnings less predictable, limiting the durability of current profit improvement.

Weak Cash-Flow Conversion

Positive cash flow in FY2026 has not yet translated into dependable cash generation, because free cash flow was modest relative to reported profit and fell sharply year over year. The prior-year cash burn highlights continuing execution risk around working capital and reinvestment.

Low Return On Equity

A very low return on equity indicates that Nureca is currently generating limited profit from the capital invested in the business. Unless profitability improves materially, the substantial equity base may remain underutilized, reducing capital efficiency and limiting the quality of earnings growth.

Nureca Ltd. News

NURECA FAQ

What was Nureca Ltd.’s price range in the past 12 months?
Nureca Ltd. lowest stock price was ₹200.10 and its highest was ₹375.00 in the past 12 months.
What is Nureca Ltd.’s market cap?
Nureca Ltd.’s market cap is ₹2.85B.
When is Nureca Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nureca Ltd.’s earnings last quarter?
Nureca Ltd. released its earnings results on Oct 21, 2026. The company reported ₹4.246 earnings per share for the quarter.
Is Nureca Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Nureca Ltd. pay dividends?
Nureca Ltd. pays a Semiannually dividend of ₹3 which represents an annual dividend yield of ―. See more information on Nureca Ltd. dividends here
What is Nureca Ltd.’s EPS estimate?
Nureca Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nureca Ltd. have?
Nureca Ltd. has 9,541,920 shares outstanding.
What happened to Nureca Ltd.’s price movement after its last earnings report?
Nureca Ltd. reported an EPS of ₹4.246 in its last earnings report. Following the earnings report the stock price went up 4.687%.
Which hedge fund is a major shareholder of Nureca Ltd.?
Currently, no hedge funds are holding shares in IN:NURECA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology